Logo do repositório
 

Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience

dc.contributor.authorBaptista, Daniela [UNESP]
dc.contributor.authorBussadori, Karina
dc.contributor.authorNunes-de-Souza, Ricardo Luiz [UNESP]
dc.contributor.authorCanto-de-Souza, Azair [UNESP]
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:25:00Z
dc.date.available2014-05-20T13:25:00Z
dc.date.issued2009-10-06
dc.description.abstractIntra-amygdala infusion of midazolam, a benzodiazepine receptor agonist, produces anxiolytic-like effects in mice when first exposed to the elevated plus-maze (EPM) and blocks antinociception induced in mice confined in the open arm of the EPM. However, benzodiazepines fail to alter anxiety in maze-experienced rodents, a phenomenon defined as "one-trial tolerance" (OTT). The main purpose of the present study was to investigate whether intra-amygdala midazolam attenuates the open ann-induced antinociception (OAA) in maze-experienced mice. Nociception was assessed by the writhing test (intraperitoneal injection of 0.6% acetic acid). In Experiment 1, nociception was recorded in maze-experienced mice without prior drug treatment. Experiment 2 investigated the effects of systemic midazolam (0.5, 1.0 and 2.0 mg/kg, s.c.), injected before EPM trial 2, on OAA in maze-experienced mice. in Experiment 3, the effects on OAA of intra-amygdala midazolam (30 nmol/0.1 mu l), injected before trial 1 (maze-naive) or before trial 2 (maze-experienced), were observed. The effects on OAA of intra-amygdala midazolam injected before trial 1 and trial 2 were also investigated (Experiment 4). The results showed that OAA remained unchanged in maze-experienced mice and was insensitive to systemic midazolam. However, intra-amygdala midazolam attenuated OAA in maze-naive mice, but not in maze-experienced mice. Even when given before both trial 1 and trial 2, intra-amygdala midazolam failed to alter OAA in maze-experienced mice. Taken together, these results confirm that the GABA(A)/benzodiazepine receptor complex located within the amygdala plays a role in OAA in maze-naive mice. The lack of effects following systemic or intra-amygdala midazolam on OAA in maze-experienced mice suggests that the OTT is also observed in the modulation of nociception and that the GABA(A)/benzodiazepine receptor located within this limbic forebrain structure participates in this process. (C) 2009 Elsevier B.V. All rights reserved.en
dc.description.affiliationUniversidade Federal de São Carlos (UFSCar), CECH, Dept Psicol, Grp Psicobiol, BR-13565905 São Carlos, SP, Brazil
dc.description.affiliationUniversidade Federal de São Carlos (UFSCar), UNESP, Programa Posgrad Ciencias Fisiol, BR-13565905 São Carlos, SP, Brazil
dc.description.affiliationSão Paulo State Univ, UNESP, Pharmacol Lab, Sch Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationUnespUniversidade Federal de São Carlos (UFSCar), UNESP, Programa Posgrad Ciencias Fisiol, BR-13565905 São Carlos, SP, Brazil
dc.description.affiliationUnespSão Paulo State Univ, UNESP, Pharmacol Lab, Sch Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipIdFAPESP: 06/06855-4
dc.description.sponsorshipIdCNPq: 309407/2006-0
dc.format.extent29-37
dc.identifierhttp://dx.doi.org/10.1016/j.brainres.2009.07.055
dc.identifier.citationBrain Research. Amsterdam: Elsevier B.V., v. 1294, p. 29-37, 2009.
dc.identifier.doi10.1016/j.brainres.2009.07.055
dc.identifier.issn0006-8993
dc.identifier.urihttp://hdl.handle.net/11449/7906
dc.identifier.wosWOS:000270658500004
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofBrain Research
dc.relation.ispartofjcr3.125
dc.relation.ispartofsjr1,404
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectFearen
dc.subjectAntinociceptionen
dc.subjectAmygdalaen
dc.subjectMidazolamen
dc.subjectElevated plus-mazeen
dc.subjectMiceen
dc.titleBlockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experienceen
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentPrincípios Ativos Naturais e Toxicologia - FCFpt

Arquivos

Licença do pacote

Agora exibindo 1 - 2 de 2
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: